The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK Cu (Copper Peptide) Provider Supervised Therapy IV Glow Bar FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn FDA Peptide Reclassification 2026 Amanecia Health GHK Cu 100mg Nova Life Peptides FDA Peptide Reclassification 2026: What Researchers Want